Cytokine inhibition: a new therapeutic avenue for skeletal diseases.
Hofbauer
Lorenz C
LC
Kühne
Christian A
CA
D000818:Animals; D001847:Bone Diseases / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D016207:Cytokines / Q000037:antagonists & inhibitors*; D015316:Genetic Therapy; D006023:Glycoproteins / Q000627:therapeutic use*; D006801:Humans; D053244:Osteoprotegerin; D018160:Receptors, Cytoplasmic and Nuclear / Q000627:therapeutic use*; D018124:Receptors, Tumor Necrosis Factor
D016207:Cytokines; D006023:Glycoproteins; D053244:Osteoprotegerin; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C506030:TNFRSF11B protein, human